Drugs / AD-206
last change Jun 2020 re-read 2 minutes ago

AD-206

Investigated by
Addpharma Inc.

Trials 1 · a red edge is where a trial was stopped

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03980756 Jun 2019 → Apr 2020 gastritis Addpharma Inc. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AD-206 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03980756